Confirming that glioma cell TrkB activation mediates the change in glutamate-evoked current amplitude, NTRK2 knockout prevented the BDNF-induced increase in glutamate-evoked inward current amplitude, compared with NTRK2 wild-type glioma xenografted cells (Fig. 2b,c). This evidence concerns the gene NTRK2 and central nervous system cancer.